230 related articles for article (PubMed ID: 17691981)
1. The role of glutamate and its receptors in migraine.
Vikelis M; Mitsikostas DD
CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):251-7. PubMed ID: 17691981
[TBL] [Abstract][Full Text] [Related]
2. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway.
Andreou AP; Goadsby PJ
Cephalalgia; 2011 Oct; 31(13):1343-58. PubMed ID: 21893557
[TBL] [Abstract][Full Text] [Related]
3. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
[TBL] [Abstract][Full Text] [Related]
4. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
[TBL] [Abstract][Full Text] [Related]
5. Sensitization, glutamate, and the link between migraine and fibromyalgia.
Sarchielli P; Di Filippo M; Nardi K; Calabresi P
Curr Pain Headache Rep; 2007 Oct; 11(5):343-51. PubMed ID: 17894924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D
J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725
[TBL] [Abstract][Full Text] [Related]
7. The link between glutamate and migraine.
Ramadan NM
CNS Spectr; 2003 Jun; 8(6):446-9. PubMed ID: 12858134
[TBL] [Abstract][Full Text] [Related]
8. Neurochemistry of trigeminal activation in an animal model of migraine.
Oshinsky ML; Luo J
Headache; 2006 Jun; 46 Suppl 1():S39-44. PubMed ID: 16927963
[TBL] [Abstract][Full Text] [Related]
9. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
Abraham KE; McGinty JF; Brewer KL
Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
[TBL] [Abstract][Full Text] [Related]
10. Testing the Role of Glutamate NMDA Receptors in Peripheral Trigeminal Nociception Implicated in Migraine Pain.
Guerrero-Toro C; Koroleva K; Ermakova E; Gafurov O; Abushik P; Tavi P; Sitdikova G; Giniatullin R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163452
[TBL] [Abstract][Full Text] [Related]
11. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin-induced glutamate release is implicated in nociceptive processing through activation of ionotropic glutamate receptors and group I metabotropic glutamate receptor in primary afferent fibers.
Jin YH; Yamaki F; Takemura M; Koike Y; Furuyama A; Yonehara N
J Pharmacol Sci; 2009 Feb; 109(2):233-41. PubMed ID: 19202316
[TBL] [Abstract][Full Text] [Related]
13. Glutamate and Its Receptors as Therapeutic Targets for Migraine.
Hoffmann J; Charles A
Neurotherapeutics; 2018 Apr; 15(2):361-370. PubMed ID: 29508147
[TBL] [Abstract][Full Text] [Related]
14. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
15. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors.
Bráuner-Osborne H; Nielsen B; Stensbøl TB; Johansen TN; Skjaerbaek N; Krogsgaard-Larsen P
Eur J Pharmacol; 1997 Sep; 335(2-3):R1-3. PubMed ID: 9369383
[TBL] [Abstract][Full Text] [Related]
16. An update on the role of glutamate in the pathophysiology of depression.
Mitchell ND; Baker GB
Acta Psychiatr Scand; 2010 Sep; 122(3):192-210. PubMed ID: 20105149
[TBL] [Abstract][Full Text] [Related]
17. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
18. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles.
Cairns BE; Sessle BJ; Hu JW
J Neurosci; 1998 Oct; 18(19):8056-64. PubMed ID: 9742172
[TBL] [Abstract][Full Text] [Related]
19. alpha-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors.
Funchal C; de Lima Pelaez P; Loureiro SO; Vivian L; Dall Bello Pessutto F; de Almeida LM; Tchernin Wofchuk S; Wajner M; Pessoa Pureur R
Brain Res Dev Brain Res; 2002 Dec; 139(2):267-76. PubMed ID: 12480141
[TBL] [Abstract][Full Text] [Related]
20. Postsynaptic modulation of AMPA- and NMDA-receptor currents by Group III metabotropic glutamate receptors in rat nucleus accumbens.
Taverna S; Pennartz CM
Brain Res; 2003 Jun; 976(1):60-8. PubMed ID: 12763622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
